Floatz logo

13 assets in Cerebrovascular Disorder

Therapeutic assets addressing Cerebrovascular Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Warfarin
Cerebrovascular Disorder
Seoul National University HospitalP4BBB (74)
Aspirin
Cerebrovascular Disorder
Peking Union Medical College HospitalP3BB (67)
Cilostazol
Cerebrovascular Disorder
Zhejiang Provincial People's HospitalP3BB (66)
Atorvastatin
Cerebrovascular Disorder
Sichuan Provincial People's HospitalP4BB (65)
Clopidogrel
Cerebrovascular Disorder
Peking Union Medical College HospitalP3BB (64)
Tenecteplase
Cerebrovascular Disorder
University of MelbourneP3BB (64)
Tirofiban
Cerebrovascular Disorder
Peking Union Medical College HospitalP3BB (64)
Dimethyloxobuthylphosphonilmethylate
Cerebrovascular Disorder
Tatchempharmpreparaty, JSCP3B (60)
Tongmai Jiangtang
Cerebrovascular Disorder
Guangdong Provincial Hospital of Traditional Chinese MedicineP3B (60)
Apsolol
Cerebrovascular Disorder
Tianjin Medical University General HospitalP2CCC (53)
Ceftriaxone
Cerebrovascular Disorder
Tianjin Medical University General HospitalP2CCC (53)
Tebonin Forte
Cerebrovascular Disorder
National Neuroscience InstituteP2CCC (53)
Ezetimibe
Cerebrovascular Disorder
Seoul National University HospitalN/AD (30)